The development of therapeutic antibodies against dengue virus

Antiviral Research

Volumn 128, Issue , 2016, Pages 7-19

  Fibriansah, Guntur ^a,b   Lok, Shee Mei ^a,b  

^a DUKE NUS MEDICAL SCHOOL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Antibody; Dengue virus; Flavivirus; Neutralization mechanism; Therapeutic antibodies

Indexed keywords

DENGUE VIRUS ANTIBODY; DIMER; E PROTEIN; EPITOPE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY DI; MONOCLONAL ANTIBODY DIII; MUTANT PROTEIN; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS GLYCOPROTEIN;

ANTIBODY DEPENDENT ENHANCEMENT; ANTIGEN ANTIBODY COMPLEX; DENGUE VIRUS; DENGUE VIRUS 2; GENOTYPE; HUMAN; MOLECULAR MECHANICS; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN QUATERNARY STRUCTURE; REVIEW; SEQUENCE ALIGNMENT; SEROTYPE; SPECIES DIFFERENCE; TEMPERATURE; VIRUS INFECTION; VIRUS MORPHOLOGY; VIRUS NEUTRALIZATION; ANIMAL; DENGUE; DISEASE MODEL; IMMUNOLOGY; ISOLATION AND PURIFICATION; MOUSE;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; DENGUE; DENGUE VIRUS; DISEASE MODELS, ANIMAL; HUMANS; MICE;

EID: 84957603435     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2016.01.002     Document Type: Review

References (104)

1. S.K. Austin, K.A. Dowd, B. Shrestha, C.A. Nelson, M.A. Edeling, S. Johnson, T.C. Pierson, M.S. Diamond, and D.H. Fremont Structural basis of differential neutralization of DENV-1 genotypes by an antibody that recognizes a cryptic epitope PLoS Pathog. 8 2012 e1002930
2. N.V. Ayala-Nunez, J. Wilschut, and J.M. Smit Monitoring virus entry into living cells using DiD-labeled dengue virus particles Methods 55 2011 137 143
3. S.J. Balsitis, K.L. Williams, R. Lachica, D. Flores, J.L. Kyle, E. Mehlhop, S. Johnson, M.S. Diamond, P.R. Beatty, and E. Harris Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification PLoS Pathog. 6 2010 e1000790
4. M. Beltramello, K.L. Williams, C.P. Simmons, A. Macagno, L. Simonelli, N.T. Quyen, S. Sukupolvi-Petty, E. Navarro-Sanchez, P.R. Young, A.M. de Silva, F.A. Rey, L. Varani, S.S. Whitehead, M.S. Diamond, E. Harris, A. Lanzavecchia, and F. Sallusto The human immune response to dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity Cell Host Microbe 8 2010 271 283
5. S. Bhatt, P.W. Gething, O.J. Brady, J.P. Messina, A.W. Farlow, C.L. Moyes, J.M. Drake, J.S. Brownstein, A.G. Hoen, O. Sankoh, M.F. Myers, D.B. George, T. Jaenisch, G.R. Wint, C.P. Simmons, T.W. Scott, J.J. Farrar, and S.I. Hay The global distribution and burden of dengue Nature 496 2013 504 507
6. M.R. Capeding, N.H. Tran, S.R. Hadinegoro, H.I. Ismail, T. Chotpitayasunondh, M.N. Chua, C.Q. Luong, K. Rusmil, D.N. Wirawan, R. Nallusamy, P. Pitisuttithum, U. Thisyakorn, I.K. Yoon, D. van der Vliet, E. Langevin, T. Laot, Y. Hutagalung, C. Frago, M. Boaz, T.A. Wartel, N.G. Tornieporth, M. Saville, A. Bouckenooghe, and C.Y.D.S. Group Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial Lancet 384 2014 1358 1365
7. X. Carnec, L. Meertens, O. Dejarnac, M. Perera-Lecoin, M. Lamine Hafirassou, J. Kitaura, R. Ramdasi, O. Schwartz, and A. Amara The phosphatidylserine and phosphatidylethanolamine receptor CD300a binds dengue virus and enhances infection J. Virol 90 2015 92 102
8. Y. Chen, T. Maguire, R.E. Hileman, J.R. Fromm, J.D. Esko, R.J. Linhardt, and R.M. Marks Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate Nat. Med. 3 1997 866 871
9. M.V. Cherrier, B. Kaufmann, G.E. Nybakken, S.M. Lok, J.T. Warren, B.R. Chen, C.A. Nelson, V.A. Kostyuchenko, H.A. Holdaway, P.R. Chipman, R.J. Kuhn, M.S. Diamond, M.G. Rossmann, and D.H. Fremont Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody EMBO J. 28 2009 3269 3276
10. J.J. Chu, and M.L. Ng Infectious entry of West Nile virus occurs through a clathrin-mediated endocytic pathway J. Virol. 78 2004 10543 10555
11. J.J. Cockburn, M.E. Navarro Sanchez, N. Fretes, A. Urvoas, I. Staropoli, C.M. Kikuti, L.L. Coffey, F. Arenzana Seisdedos, H. Bedouelle, and F.A. Rey Mechanism of dengue virus broad cross-neutralization by a monoclonal antibody Structure 20 2012 303 314
12. J.J. Cockburn, M.E. Navarro Sanchez, A.P. Goncalvez, E. Zaitseva, E.A. Stura, C.M. Kikuti, S. Duquerroy, P. Dussart, L.V. Chernomordik, C.J. Lai, and F.A. Rey Structural insights into the neutralization mechanism of a higher primate antibody against dengue virus EMBO J. 31 2012 767 779
13. B.A. Coller, D.E. Clements, A.J. Bett, S.L. Sagar, and J.H. Ter Meulen The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease Vaccine 29 2011 7267 7275
14. W.D. Crill, H.R. Hughes, M.J. Delorey, and G.J. Chang Humoral immune responses of dengue fever patients using epitope-specific serotype-2 virus-like particle antigens PloS One 4 2009 e4991
15. W.D. Crill, and J.T. Roehrig Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to vero cells J. Virol. 75 2001 7769 7773
16. R. de Alwis, S.A. Smith, N.P. Olivarez, W.B. Messer, J.P. Huynh, W.M. Wahala, L.J. White, M.S. Diamond, R.S. Baric, J.E. Crowe Jr., and A.M. de Silva Identification of human neutralizing antibodies that bind to complex epitopes on dengue Virions Proc. Natl. Acad. Sci. U. S. A. 109 2012 7439 7444
17. R. de Alwis, K.L. Williams, M.A. Schmid, C.Y. Lai, B. Patel, S.A. Smith, J.E. Crowe, W.K. Wang, E. Harris, and A.M. de Silva Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera PLoS Pathog. 10 2014 e1004386
18. W. Dejnirattisai, A.I. Webb, V. Chan, A. Jumnainsong, A. Davidson, J. Mongkolsapaya, and G. Screaton Lectin switching during dengue virus infection J. Infect. Dis. 203 2011 1775 1783
19. W. Dejnirattisai, W. Wongwiwat, S. Supasa, X. Zhang, X. Dai, A. Rouvinsky, A. Jumnainsong, C. Edwards, N.T. Quyen, T. Duangchinda, J.M. Grimes, W.Y. Tsai, C.Y. Lai, W.K. Wang, P. Malasit, J. Farrar, C.P. Simmons, Z.H. Zhou, F.A. Rey, J. Mongkolsapaya, and G.R. Screaton A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus Nat. Immunol. 16 2015 170 177
20. K.A. Dowd, C.A. Jost, A.P. Durbin, S.S. Whitehead, and T.C. Pierson A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus PLoS Pathog. 7 2011 e1002111
21. R. Feighny, J. Burrous, and R. Putnak Dengue Type-2 virus envelope protein made using recombinant Baculovirus protects mice against virus challenge Am. J. Trop. Med. Hyg. 50 1994 322 328
22. G. Fibriansah, K.D. Ibarra, T.S. Ng, S.A. Smith, J.L. Tan, X.N. Lim, J.S. Ooi, V.A. Kostyuchenko, J. Wang, A.M. de Silva, E. Harris, J.E. Crowe Jr., and S.M. Lok Dengue Virus. cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers Science 349 2015 88 91
23. G. Fibriansah, T.S. Ng, V.A. Kostyuchenko, J. Lee, S. Lee, J. Wang, and S.M. Lok Structural changes in dengue virus when exposed to a temperature of 37 degrees C J. Virol. 87 2013 7585 7592
24. G. Fibriansah, J.L. Tan, S.A. Smith, A.R. de Alwis, T.S. Ng, V.A. Kostyuchenko, K.D. Ibarra, J. Wang, E. Harris, A. de Silva, J.E. Crowe Jr., and S.M. Lok A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface EMBO Mol. Med. 6 2014 358 371
25. G. Fibriansah, J.L. Tan, S.A. Smith, R. de Alwis, T.S. Ng, V.A. Kostyuchenko, R.S. Jadi, P. Kukkaro, A.M. de Silva, J.E. Crowe, and S.M. Lok A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins Nat. Commun. 6 2015 6341
26. R. Germi, J.M. Crance, D. Garin, J. Guimet, H. Lortat-Jacob, R.W. Ruigrok, J.P. Zarski, and E. Drouet Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus Virology 292 2002 162 168
27. G.D. Gromowski, and A.D. Barrett Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus Virology 366 2007 349 360
28. B. Guy, O. Briand, J. Lang, M. Saville, and N. Jackson Development of the Sanofi pasteur tetravalent dengue vaccine: one more step forward Vaccine 33 2015 7100 7111
29. S.B. Halstead Neutralization and antibody-dependent enhancement of dengue viruses Adv. Virus Res. 60 2003 421 467
30. P. Hilgard, and R. Stockert Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes Hepatology 32 2000 1069 1077
31. S.L. Hung, P.L. Lee, H.W. Chen, L.K. Chen, C.L. Kao, and C.C. King Analysis of the steps involved in dengue virus entry into host cells Virology 257 1999 156 167
32. A. Imrie, J. Meeks, A. Gurary, M. Sukhbaatar, T.T. Truong, C.B. Cropp, and P. Effler Antibody to dengue 1 detected more than 60 years after infection Viral Immunol. 20 2007 672 675
33. S. Jemielity, J.J. Wang, Y.K. Chan, A.A. Ahmed, W. Li, S. Monahan, X. Bu, M. Farzan, G.J. Freeman, D.T. Umetsu, R.H. Dekruyff, and H. Choe TIM-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserine PLoS Pathog. 9 2013 e1003232
34. A.J. Johnson, and J.T. Roehrig New mouse model for dengue virus vaccine testing J. Virol. 73 1999 783 786
35. B. Kaufmann, P.R. Chipman, H.A. Holdaway, S. Johnson, D.H. Fremont, R.J. Kuhn, M.S. Diamond, and M.G. Rossmann Capturing a flavivirus pre-fusion intermediate PLoS Pathog. 5 2009 e1000672
36. B. Kaufmann, G.E. Nybakken, P.R. Chipman, W. Zhang, M.S. Diamond, D.H. Fremont, R.J. Kuhn, and M.G. Rossmann West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody Proc. Natl. Acad. Sci. U. S. A. 103 2006 12400 12404
37. B. Kaufmann, M.R. Vogt, J. Goudsmit, H.A. Holdaway, A.A. Aksyuk, P.R. Chipman, R.J. Kuhn, M.S. Diamond, and M.G. Rossmann Neutralization of West Nile virus by cross-linking of its surface proteins with Fab fragments of the human monoclonal antibody CR4354 Proc. Natl. Acad. Sci. U. S. A. 107 2010 18950 18955
38. D.E. Klein, J.L. Choi, and S.C. Harrison Structure of a dengue virus envelope protein late-stage fusion intermediate J. Virol. 87 2013 2287 2293
39. A.S. Kondratowicz, N.J. Lennemann, P.L. Sinn, R.A. Davey, C.L. Hunt, S. Moller-Tank, D.K. Meyerholz, P. Rennert, R.F. Mullins, M. Brindley, L.M. Sandersfeld, K. Quinn, M. Weller, P.B. McCray Jr., J. Chiorini, and W. Maury T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus Proc. Natl. Acad. Sci. U. S. A. 108 2011 8426 8431
40. V.A. Kostyuchenko, P.L. Chew, T.S. Ng, and S.M. Lok Near-atomic resolution cryo-electron microscopic structure of dengue serotype 4 virus J. Virol. 88 2014 477 482
41. V.A. Kostyuchenko, Q. Zhang, J.L. Tan, T.S. Ng, and S.M. Lok Immature and mature dengue serotype 1 virus structures provide insight into the maturation process J. Virol. 87 2013 7700 7707
42. M.N. Krishnan, B. Sukumaran, U. Pal, H. Agaisse, J.L. Murray, T.W. Hodge, and E. Fikrig Rab 5 is required for the cellular entry of dengue and West Nile viruses J. Virol. 81 2007 4881 4885
43. R.J. Kuhn, W. Zhang, M.G. Rossmann, S.V. Pletnev, J. Corver, E. Lenches, C.T. Jones, S. Mukhopadhyay, P.R. Chipman, E.G. Strauss, T.S. Baker, and J.H. Strauss Structure of dengue virus: implications for flavivirus organization, maturation, and fusion Cell 108 2002 717 725
44. C.J. Lai, A.P. Goncalvez, R. Men, C. Wernly, O. Donau, R.E. Engle, and R.H. Purcell Epitope determinants of a chimpanzee dengue virus type 4 (DENV-4)-neutralizing antibody and protection against DENV-4 challenge in mice and rhesus monkeys by passively transferred humanized antibody J. Virol. 81 2007 12766 12774
45. C.Y. Lai, W.Y. Tsai, S.R. Lin, C.L. Kao, H.P. Hu, C.C. King, H.C. Wu, G.J. Chang, and W.K. Wang Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II J. Virol. 82 2008 6631 6643
46. E. Lee, M. Pavy, N. Young, C. Freeman, and M. Lobigs Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses Antivir. Res. 69 2006 31 38
47. G. Lemke, and C.V. Rothlin Immunobiology of the TAM receptors Nat. Rev. Immunol. 8 2008 327 336
48. H.E. Lin, W.Y. Tsai, I.J. Liu, P.C. Li, M.Y. Liao, J.J. Tsai, Y.C. Wu, C.Y. Lai, C.H. Lu, J.H. Huang, G.J. Chang, H.C. Wu, and W.K. Wang Analysis of epitopes on dengue virus envelope protein recognized by monoclonal antibodies and polyclonal human sera by a high throughput assay PLoS Negl. Trop. Dis. 6 2012 e1447
49. S.-M. Lok The interplay of dengue virus morphological diversity and human antibodies Trends Microbiol. 2015 http://dx.doi.org/10.1016/j.tim.2015.12.004
50. S.M. Lok, V. Kostyuchenko, G.E. Nybakken, H.A. Holdaway, A.J. Battisti, S. Sukupolvi-Petty, D. Sedlak, D.H. Fremont, P.R. Chipman, J.T. Roehrig, M.S. Diamond, R.J. Kuhn, and M.G. Rossmann Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins Nat. Struct. Mol. Biol. 15 2008 312 317
51. P.Y. Lozach, L. Burleigh, I. Staropoli, E. Navarro-Sanchez, J. Harriague, J.L. Virelizier, F.A. Rey, P. Despres, F. Arenzana-Seisdedos, and A. Amara Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals J. Biol. Chem. 280 2005 23698 23708
52. A. Mathew, K. West, S. Kalayanarooj, R.V. Gibbons, A. Srikiatkhachorn, S. Green, D. Libraty, S. Jaiswal, and A.L. Rothman B-cell responses during primary and secondary dengue virus infections in humans J. Infect. Dis. 204 2011 1514 1522
53. L. Meertens, X. Carnec, M.P. Lecoin, R. Ramdasi, F. Guivel-Benhassine, E. Lew, G. Lemke, O. Schwartz, and A. Amara The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry Cell Host Microbe 12 2012 544 557
54. R. Men, T. Yamashiro, A.P. Goncalvez, C. Wernly, D.J. Schofield, S.U. Emerson, R.H. Purcell, and C.J. Lai Identification of chimpanzee fab fragments by repertoire cloning and production of a full-length humanized immunoglobulin G1 antibody that is highly efficient for neutralization of dengue type 4 virus J. Virol. 78 2004 4665 4674
55. C.M. Midgley, A. Flanagan, H.B. Tran, W. Dejnirattisai, K. Chawansuntati, A. Jumnainsong, W. Wongwiwat, T. Duangchinda, J. Mongkolsapaya, J.M. Grimes, and G.R. Screaton Structural analysis of a dengue cross-reactive antibody complexed with envelope domain III reveals the molecular basis of cross-reactivity J. Immunol. 188 2012 4971 4979
56. J.L. Miller, B.J. de Wet, L. Martinez-Pomares, C.M. Radcliffe, R.A. Dwek, P.M. Rudd, and S. Gordon The mannose receptor mediates dengue virus infection of macrophages PLoS Pathog. 4 2008 e17
57. Y. Modis, S. Ogata, D. Clements, and S.C. Harrison A ligand-binding pocket in the dengue virus envelope glycoprotein Proc. Natl. Acad. Sci. U. S. A. 100 2003 6986 6991
58. Y. Modis, S. Ogata, D. Clements, and S.C. Harrison Structure of the dengue virus envelope protein after membrane fusion Nature 427 2004 313 319
59. S. Moller-Tank, A.S. Kondratowicz, R.A. Davey, P.D. Rennert, and W. Maury Role of the phosphatidylserine receptor TIM-1 in enveloped-virus entry J. Virol. 87 2013 8327 8341
60. J.A. Mondotte, P.Y. Lozach, A. Amara, and A.V. Gamarnik Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation J. Virol. 81 2007 7136 7148
61. D.M. Morens, S.B. Halstead, and N.J. Marchette Profiles of antibody-dependent enhancement of dengue virus type 2 infection Microb. Pathog. 3 1987 231 237
62. K. Morizono, and I.S. Chen Role of phosphatidylserine receptors in enveloped virus infection J. Virol. 88 2014 4275 4290
63. E. Navarro-Sanchez, R. Altmeyer, A. Amara, O. Schwartz, F. Fieschi, J.L. Virelizier, F. Arenzana-Seisdedos, and P. Despres Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses EMBO Rep. 4 2003 723 728
64. G.E. Nybakken, T. Oliphant, S. Johnson, S. Burke, M.S. Diamond, and D.H. Fremont Structural basis of West Nile virus neutralization by a therapeutic antibody Nature 437 2005 764 769
65. T. Oliphant, M. Engle, G.E. Nybakken, C. Doane, S. Johnson, L. Huang, S. Gorlatov, E. Mehlhop, A. Marri, K.M. Chung, G.D. Ebel, L.D. Kramer, D.H. Fremont, and M.S. Diamond Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus Nat. Med. 11 2005 522 530
66. T. Oliphant, G.E. Nybakken, M. Engle, Q. Xu, C.A. Nelson, S. Sukupolvi-Petty, A. Marri, B.E. Lachmi, U. Olshevsky, D.H. Fremont, T.C. Pierson, and M.S. Diamond Antibody recognition and neutralization determinants on domains I and II of West Nile virus envelope protein J. Virol. 80 2006 12149 12159
67. M. Perera-Lecoin, L. Meertens, X. Carnec, and A. Amara Flavivirus entry receptors: an update Viruses 6 2014 69 88
68. M. Poggianella, J.L. Slon Campos, K.R. Chan, H.C. Tan, M. Bestagno, E.E. Ooi, and O.R. Burrone Dengue e protein domain III-based DNA immunisation induces Strong antibody responses to all four viral serotypes PLoS Negl. Trop. Dis. 9 2015 e0003947
69. E. Pokidysheva, Y. Zhang, A.J. Battisti, C.M. Bator-Kelly, P.R. Chipman, C. Xiao, G.G. Gregorio, W.A. Hendrickson, R.J. Kuhn, and M.G. Rossmann Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN Cell 124 2006 485 493
70. J.R. Putnak, N. Kanesa-Thasan, and B.L. Innis A putative cellular receptor for dengue viruses Nat. Med. 3 1997 828 829
71. S.A. Reading, and N.J. Dimmock Neutralization of animal virus infectivity by antibody Arch. Virol. 152 2007 1047 1059
72. F.A. Rey, F.X. Heinz, C. Mandl, C. Kunz, and S.C. Harrison The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution Nature 375 1995 291 298
73. A.S. Richard, A. Zhang, S.J. Park, M. Farzan, M. Zong, and H. Choe Virion-associated phosphatidylethanolamine promotes TIM1-mediated infection by Ebola, dengue, and West Nile viruses Proc. Natl. Acad. Sci. U. S. A. 112 2015 14682 14687
74. M.K. Richter, J.M. da Silva Voorham, S. Torres Pedraza, T.E. Hoornweg, D.P. van de Pol, I.A. Rodenhuis-Zybert, J. Wilschut, and J.M. Smit Immature dengue virus is infectious in human immature dendritic cells via interaction with the receptor molecule DC-SIGN PloS One 9 2014 e98785
75. L.N. Robinson, K. Tharakaraman, K.J. Rowley, V.V. Costa, K.R. Chan, Y.H. Wong, L.C. Ong, H.C. Tan, T. Koch, D. Cain, R. Kirloskar, K. Viswanathan, C.W. Liew, H. Tissire, B. Ramakrishnan, J.R. Myette, G.J. Babcock, V. Sasisekharan, S. Alonso, J. Chen, J. Lescar, Z. Shriver, E.E. Ooi, and R. Sasisekharan Structure-guided design of an anti-dengue antibody directed to a non-immunodominant epitope Cell 162 2015 493 504
76. M.J. Robinson, D. Sancho, E.C. Slack, S. LeibundGut-Landmann, and C. Reis e Sousa Myeloid C-type lectins in innate immunity Nat. Immunol. 7 2006 1258 1265
77. J.T. Roehrig Antigenic structure of flavivirus proteins Adv. Virus Res. 59 2003 141 175
78. J.T. Roehrig, R.A. Bolin, and R.G. Kelly Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica Virology 246 1998 317 328
79. A. Rouvinski, P. Guardado-Calvo, G. Barba-Spaeth, S. Duquerroy, M.C. Vaney, C.M. Kikuti, M.E. Navarro Sanchez, W. Dejnirattisai, W. Wongwiwat, A. Haouz, C. Girard-Blanc, S. Petres, W.E. Shepard, P. Desprès, F. Arenzana-Seisdedos, P. Dussart, J. Mongkolsapaya, G.R. Screaton, and F.A. Rey Recognition determinants of broadly neutralizing human antibodies against dengue viruses Nature 520 2015 109 113
80. A. Sabchareon, D. Wallace, C. Sirivichayakul, K. Limkittikul, P. Chanthavanich, S. Suvannadabba, V. Jiwariyavej, W. Dulyachai, K. Pengsaa, T.A. Wartel, A. Moureau, M. Saville, A. Bouckenooghe, S. Viviani, N.G. Tornieporth, and J. Lang Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial Lancet 380 2012 1559 1567
81. B. Shrestha, J.D. Brien, S. Sukupolvi-Petty, S.K. Austin, M.A. Edeling, T. Kim, K.M. O'Brien, C.A. Nelson, S. Johnson, D.H. Fremont, and M.S. Diamond The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1 PLoS Pathog. 6 2010 e1000823
82. S.A. Smith, A.R. de Alwis, N. Kose, E. Harris, K.D. Ibarra, K.M. Kahle, J.M. Pfaff, X. Xiang, B.J. Doranz, A.M. de Silva, S.K. Austin, S. Sukupolvi-Petty, M.S. Diamond, and J.E. Crowe Jr The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein MBio 4 2013 e00873 e00913
83. S.A. Smith, Y. Zhou, N.P. Olivarez, A.H. Broadwater, A.M. de Silva, and J.E. Crowe Jr. Persistence of circulating memory B cell clones with potential for dengue virus disease enhancement for decades following infection J. Virol. 86 2012 2665 2675
84. S. Sukupolvi-Petty, S.K. Austin, M. Engle, J.D. Brien, K.A. Dowd, K.L. Williams, S. Johnson, R. Rico-Hesse, E. Harris, T.C. Pierson, D.H. Fremont, and M.S. Diamond Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2 J. Virol. 84 2010 9227 9239
85. S. Sukupolvi-Petty, S.K. Austin, W.E. Purtha, T. Oliphant, G.E. Nybakken, J.J. Schlesinger, J.T. Roehrig, G.D. Gromowski, A.D. Barrett, D.H. Fremont, and M.S. Diamond Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes J. Virol. 81 2007 12816 12826
86. M.H. Tao, and S.L. Morrison Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region J. Immunol. 143 1989 2595 2601
87. B. Tassaneetrithep, T.H. Burgess, A. Granelli-Piperno, C. Trumpfheller, J. Finke, W. Sun, M.A. Eller, K. Pattanapanyasat, S. Sarasombath, D.L. Birx, R.M. Steinman, S. Schlesinger, and M.A. Marovich DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells J. Exp. Med. 197 2003 823 829
88. E.P. Teoh, P. Kukkaro, E.W. Teo, A.P. Lim, T.T. Tan, A. Yip, W. Schul, M. Aung, V.A. Kostyuchenko, Y.S. Leo, S.H. Chan, K.G. Smith, A.H. Chan, G. Zou, E.E. Ooi, D.M. Kemeny, G.K. Tan, J.K. Ng, M.L. Ng, S. Alonso, D. Fisher, P.Y. Shi, B.J. Hanson, S.M. Lok, and P.A. MacAry The structural basis for serotype-specific neutralization of dengue virus by a human antibody Sci. Transl. Med. 4 2012 139 183
89. S.J. Thomas, and T.P. Endy Critical issues in dengue vaccine development Curr. Opin. Infect. Dis. 24 2011 442 450
90. P. Thullier, P. Lafaye, F. Megret, V. Deubel, A. Jouan, and J.C. Mazie A recombinant Fab neutralizes dengue virus in vitro J. Biotechnol. 69 1999 183 190
91. W.Y. Tsai, C.Y. Lai, Y.C. Wu, H.E. Lin, C. Edwards, A. Jumnainsong, S. Kliks, S. Halstead, J. Mongkolsapaya, G.R. Screaton, and W.K. Wang High-avidity and potently neutralizing cross-reactive human monoclonal antibodies derived from secondary dengue virus infection J. Virol. 87 2013 12562 12575
92. H.M. van der Schaar, M.J. Rust, C. Chen, H. van der Ende-Metselaar, J. Wilschut, X. Zhuang, and J.M. Smit Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells PLoS Pathog. 4 2008 e1000244
93. L. Villar, G.H. Dayan, J.L. Arredondo-Garcia, D.M. Rivera, R. Cunha, C. Deseda, H. Reynales, M.S. Costa, J.O. Morales-Ramirez, G. Carrasquilla, L.C. Rey, R. Dietze, K. Luz, E. Rivas, M.C. Miranda Montoya, M. Cortes Supelano, B. Zambrano, E. Langevin, M. Boaz, N. Tornieporth, M. Saville, F. Noriega, and C.Y.D.S. Group Efficacy of a tetravalent dengue vaccine in children in Latin America N. Engl. J. Med. 372 2015 113 123
94. M.R. Vogt, B. Moesker, J. Goudsmit, M. Jongeneelen, S.K. Austin, T. Oliphant, S. Nelson, T.C. Pierson, J. Wilschut, M. Throsby, and M.S. Diamond Human monoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment step J. Virol. 83 2009 6494 6507
95. W.M. Wahala, A.A. Kraus, L.B. Haymore, M.A. Accavitti-Loper, and A.M. de Silva Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody Virology 392 2009 103 113
96. S. Watanabe, K.W. Chan, J. Wang, L. Rivino, S.M. Lok, and S.G. Vasudevan Dengue virus infection with highly neutralizing levels of cross-reactive antibodies causes acute lethal small intestinal pathology without a high level of viremia in mice J. Virol. 89 2015 5847 5861
97. D. Watterson, B. Kobe, and P.R. Young Residues in domain III of the dengue virus envelope glycoprotein involved in cell-surface glycosaminoglycan binding J. Gen. Virol. 93 2012 72 82
98. K.L. Williams, S. Sukupolvi-Petty, M. Beltramello, S. Johnson, F. Sallusto, A. Lanzavecchia, M.S. Diamond, and E. Harris Therapeutic efficacy of antibodies lacking Fcgamma receptor binding against lethal dengue virus infection is due to neutralizing potency and blocking of enhancing antibodies [corrected] PLoS Pathog. 9 2013 e1003157
99. K.L. Williams, S. Zompi, P.R. Beatty, and E. Harris A mouse model for studying dengue virus pathogenesis and immune response Ann. N. Y. Acad. Sci. 1171 Suppl. 1 2009 E12 E23
100. X. Zhang, P. Ge, X. Yu, J.M. Brannan, G. Bi, Q. Zhang, S. Schein, and Z.H. Zhou Cryo-EM structure of the mature dengue virus at 3.5-A resolution Nat. Struct. Mol. Biol. 20 2013 105 110
101. X. Zhang, J. Sheng, S.K. Austin, T.E. Hoornweg, J.M. Smit, R.J. Kuhn, M.S. Diamond, and M.G. Rossmann Structure of acidic pH dengue virus showing the fusogenic glycoprotein trimers J. Virol. 89 2015 743 750
102. X. Zhang, J. Sheng, P. Plevka, R.J. Kuhn, M.S. Diamond, and M.G. Rossmann Dengue structure differs at the temperatures of its human and mosquito hosts Proc. Natl. Acad. Sci. U. S. A. 110 2013 6795 6799
103. Y. Zhou, S.K. Austin, D.H. Fremont, B.L. Yount, J.P. Huynh, A.M. de Silva, R.S. Baric, and W.B. Messer The mechanism of differential neutralization of dengue serotype 3 strains by monoclonal antibody 8A1 Virology 439 2013 57 64
104. S. Zompi, M. Montoya, M.O. Pohl, A. Balmaseda, and E. Harris Dominant cross-reactive B cell response during secondary acute dengue virus infection in humans PLoS Negl. Trop. Dis. 6 2012 e1568